AIkido Pharma Inc. (NASDAQ:AIKI) went down by -0.90% from its latest closing price compared to the recent 1-year high of $5.46. The company’s stock price has collected 25.93% of gains in the last five trading sessions. Press Release reported on 01/06/21 that AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer Applications
Is It Worth Investing in AIkido Pharma Inc. (NASDAQ :AIKI) Right Now?
Plus, the 36-month beta value for AIKI is at 1.92. Opinions of the stock are interesting as 0 analysts out of 0 who provided ratings for AIkido Pharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $1802.25. AIKI currently public float of 32.96M and currently shorts hold a 2.10% ratio of that float. Today, the average trading volume of AIKI was 6.95M shares.
AIKI’s Market Performance
AIKI stocks went up by 25.93% for the week, with a monthly jump of 63.84% and a quarterly performance of 72.79%, while its annual performance rate touched -13.76%. The volatility ratio for the week stands at 23.27% while the volatility levels for the past 30 days are set at 19.24% for AIkido Pharma Inc.. The simple moving average for the period of the last 20 days is 50.83% for AIKI stocks with a simple moving average of 53.57% for the last 200 days.
AIKI Trading at 78.84% from the 50-Day Moving Average
After a stumble in the market that brought AIKI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.85% of loss for the given period.
Volatility was left at 19.24%, however, over the last 30 days, the volatility rate increased by 23.27%, as shares surge +57.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +103.67% upper at present.
During the last 5 trading sessions, AIKI rose by +25.93%, which changed the moving average for the period of 200-days by +71.88% in comparison to the 20-day moving average, which settled at $0.7494. In addition, AIkido Pharma Inc. saw 25.93% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AIKI
Current profitability levels for the company are sitting at:
- -63166.67 for the present operating margin
The net margin for AIkido Pharma Inc. stands at -46477.78. The total capital return value is set at -50.24, while invested capital returns managed to touch -36.97. Equity return is now at value -50.70, with -49.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.51.